{"id":48,"count":6,"description":"<div class=\"scroll-box\">\r\n<h2 style=\"text-align: center\">Raziskovanje peptidov GLP-1: Raziskovalne aplikacije pri presnovi in uravnavanju apetita<\/h2>\r\n<em>Peptidi GLP-1 so kategorija raziskovalnih spojin, ki se preu\u010dujejo zaradi njihovih u\u010dinkov na uravnavanje krvnega sladkorja, zatiranje apetita in presnovno ravnovesje. Ti peptidi opona\u0161ajo ali spodbujajo delovanje glukagonu podobnega peptida-1, hormona, ki ima osrednjo vlogo pri glukozni homeostazi in vnosu energije. V laboratorijskih okoljih se peptidi GLP-1 pogosto raziskujejo glede njihovega potenciala v modelih debelosti, sladkorne bolezni tipa 2 in uravnavanja telesne te\u017ee. <\/em>\r\n\r\nGLP-1 peptides are a class of research compounds that mimic or enhance the activity of glucagon-like peptide-1, a hormone involved in appetite control, insulin secretion, and glucose metabolism. In scientific studies, these peptides are explored for their ability to suppress hunger, promote fat loss, and regulate blood sugar levels, making them a major focus in research targeting obesity, type 2 diabetes, and other metabolic disorders.\r\n\r\nGLP-1 receptor agonists work by activating incretin pathways (GLP-1, GIP, and glucagon receptors), which collectively help improve insulin sensitivity, slow gastric emptying, reduce food intake, and increase metabolic expenditure. More advanced compounds in this class also target multiple receptors to enhance metabolic effects, offering new possibilities for studying complex weight-related mechanisms in lab settings.\r\n\r\n<em><strong>Izjava o omejitvi odgovornosti: <\/strong>Vsi tukaj omenjeni peptidi GLP-1 so namenjeni izklju\u010dno uporabi v laboratorijskih raziskavah. Vse omenjene posledice za ljudi temeljijo izklju\u010dno na ugotovitvah iz \u017eivalskih modelov ali klini\u010dnih podatkov in jih ni mogo\u010de razlagati kot medicinski nasvet ali terapevtska priporo\u010dila.<\/em>\r\n<h2>Kaj so peptidi agonisti receptorjev GLP-1?<\/h2>\r\nGLP-1 receptor agonist peptides are synthetic compounds designed to replicate or enhance the effects of glucagon-like peptide-1 (GLP-1), an incretin hormone released by the gut after eating. In research settings, GLP-1 is known for its ability to stimulate insulin secretion, suppress appetite, slow gastric emptying, and regulate blood sugar. However, the natural hormone breaks down quickly in the body, prompting the development of longer-lasting analogs for laboratory use.\r\n\r\nModern GLP-1 peptides are engineered for increased stability and often include multi-receptor activity. In addition to GLP-1 activation, some of these peptides also target:\r\n<ul>\r\n \t<li><strong>GIP (glukoza odvisni insulinotropni polipeptid):<\/strong> Sp spodbuja izlo\u010danje inzulina in vpliva na presnovo ma\u0161\u010dob<\/li>\r\n \t<li><strong>Glukagonski receptorji:<\/strong> Sp spodbuja oksidacijo ma\u0161\u010dob, termogenezo in porabo energije<\/li>\r\n<\/ul>\r\nTi skupni u\u010dinki delajo agoniste receptorjev GLP-1 dragocene v klini\u010dnih raziskovalnih modelih, osredoto\u010denih na:\r\n<ul>\r\n \t<li>Izguba te\u017ee in zatiranje apetita<\/li>\r\n \t<li>Debelost in metabolni sindrom<\/li>\r\n \t<li>Inzulinska rezistenca in glukozna homeostaza<\/li>\r\n \t<li>\u0160tudije ma\u0161\u010dobne mase in energijskega ravnovesja<\/li>\r\n<\/ul>\r\nPeptidi, kot so semaglutid, tirzepatid in retatrutid, se v tej raziskovalni kategoriji pogosto uporabljajo zaradi svojih mo\u010dnih presnovnih u\u010dinkov in u\u010dinkov zmanj\u0161evanja telesne te\u017ee.\r\n<h2>Mehanizmi delovanja peptidov GLP-1<\/h2>\r\nGLP-1 receptor agonist peptides work by mimicking or enhancing natural gut hormones that regulate hunger, insulin release, and energy metabolism. Each peptide in this category acts on different combinations of receptors to drive metabolic effects. Here's a breakdown of the mechanisms by individual peptide:\r\n\r\n<strong>Semaglutid<\/strong>\r\n<ul>\r\n \t<li>Kot agonist receptorjev GLP-1 semaglutid opona\u0161a naravne hormone inkretine.<\/li>\r\n \t<li>Upo\u010dasnjuje praznjenje \u017eelodca, s \u010dimer podalj\u0161uje ob\u010dutek sitosti in zmanj\u0161uje vnos kalorij.<\/li>\r\n \t<li>Sp spodbuja izlo\u010danje insulina kot odziv na glukozo in zni\u017euje raven krvnega sladkorja.<\/li>\r\n \t<li>Njegova dolgodelujo\u010da zasnova podpira odmerjanje enkrat na teden v raziskovalnih modelih in ohranja stabilno aktivacijo receptorjev skozi \u010das.<\/li>\r\n<\/ul>\r\n<strong>Tirzepatid<\/strong>\r\n<ul>\r\n \t<li>Dvojni agonist receptorjev za GLP-1 in GIP (glukozi odvisni insulinotropni polipeptid).<\/li>\r\n \t<li>Izbolj\u0161uje ob\u010dutljivost za inzulin in njegovo izlo\u010danje ter hkrati uravnava raven glukagona.<\/li>\r\n \t<li>Mo\u010dno zavira apetit in izbolj\u0161uje glikemi\u010dni nadzor, kar vodi do opazne izgube te\u017ee.<\/li>\r\n \t<li>V klini\u010dnih \u0161tudijah SURPASS je tirzepatid preka\u0161al semaglutid pri zmanj\u0161evanju telesne te\u017ee in krvnega sladkorja.<\/li>\r\n<\/ul>\r\n<strong>Retatrutid<\/strong>\r\n<ul>\r\n \t<li>Trojni agonist receptorjev, usmerjen na receptorje za GLP-1, GIP in glukagon.<\/li>\r\n \t<li>Aktivira poti glukagona za pove\u010danje porabe energije in bazalnega metabolizma.<\/li>\r\n \t<li>Spodbuja lipolizo in oksidacijo ma\u0161\u010dob, zaradi \u010desar je eden najmo\u010dnej\u0161ih peptidov, preu\u010devanih za zmanj\u0161evanje telesne ma\u0161\u010dobe.<\/li>\r\n \t<li>Zgodnja klini\u010dna testiranja na ljudeh ka\u017eejo ve\u010djo izgubo te\u017ee kot druge spojine na osnovi GLP-1.<\/li>\r\n<\/ul>\r\nSkupaj ti peptid predstavljajo mo\u010dan razred presnovnih regulatorjev v laboratorijskih \u0161tudijah, ki ponujajo vpogled v nadzor teka, dinamiko inzulina in energijsko ravnovesje.\r\n<h2>Raziskave in klini\u010dne ugotovitve<\/h2>\r\nPeptidni agonisti GLP-1, kot so semaglutid, tirzepatid in retatrutid, so zaradi svojih mo\u010dnih u\u010dinkov na izgubo te\u017ee, uravnavanje apetita in nadzor ravni glukoze korenito spremenili podro\u010dje presnovnih raziskav. Vsak od njih je bil preu\u010den v obse\u017enih klini\u010dnih in laboratorijskih presku\u0161anjih, ki so dala dosledno dobre rezultate:\r\n<h3>Semaglutid<\/h3>\r\n<ul>\r\n \t<li>V klini\u010dnih \u0161tudijah STEP so debeli udele\u017eenci brez sladkorne bolezni v 68 tednih izgubili povpre\u010dno ~15% svoje telesne te\u017ee.<\/li>\r\n \t<li>Pomembne zmanj\u0161ave so bile opazovane tudi pri obsegu pasu, ravni inzulina na te\u0161\u010de in vnetnih biomarkerjih.<\/li>\r\n \t<li>Udele\u017eenci so poro\u010dali o zmanj\u0161anju teka v nekaj dneh, kar je izbolj\u0161alo sodelovanje v dolgoro\u010dnih raziskovalnih protokolih.<\/li>\r\n<\/ul>\r\n<h3>Tirzepatid<\/h3>\r\n<ul>\r\n \t<li>V \u0161tudiji SURMOUNT-1 je bila v 72 tednih ugotovljena izguba telesne te\u017ee v vi\u0161ini ~22,51 TP3T.<\/li>\r\n \t<li>Tirzepatid je izbolj\u0161al tudi ravni HbA1c, ob\u010dutljivost na inzulin in lipidne profile.<\/li>\r\n \t<li>Njeno dvojno delovanje na GIP in GLP-1 jo je v neposrednih primerjalnih \u0161tudijah postavilo nad same agoniste GLP-1.<\/li>\r\n \t<li>Raziskave ka\u017eejo koristi pri presnovnih modelih s sladkorno boleznijo in brez nje.<\/li>\r\n<\/ul>\r\n<h3>Retatrutid<\/h3>\r\n<ul>\r\n \t<li>V klini\u010dnem presku\u0161anju faze II (2023) je bila pri udele\u017eencih s prekomerno telesno te\u017eo ali debelostjo ugotovljena izguba ma\u0161\u010dobe do 24,21 TP3T, kar je doslej najvi\u0161ja vrednost v skupini inkretinov.<\/li>\r\n \t<li>Z aktivacijo receptorja za glukagon je pove\u010dala porabo energije in oksidacijo ma\u0161\u010dob prek mehanizmov, ki presegajo samo mehanizme GLP-1\/GIP.<\/li>\r\n \t<li>Prav tako so pokazali koristne u\u010dinke na krvni tlak, trigliceride in ma\u0161\u010dobna jetra.<\/li>\r\n<\/ul>\r\n<strong>Splo\u0161ni vpogledi<\/strong>\r\n\r\nVsi trije peptidi dosledno ka\u017eejo:\r\n<ul>\r\n \t<li>Hitro zaviranje apetita<\/li>\r\n \t<li>Zmanj\u0161ana ma\u0161\u010dobna masa, obseg pasu in inzulin na te\u0161\u010de<\/li>\r\n \t<li>Izbolj\u0161ani kardiometaboli\u010dni ozna\u010devalci (holesterol, krvni tlak, CRP)<\/li>\r\n \t<li>Dolge razpolovne dobe so idealne za tedensko ali dvakrat tedensko raziskovalno doziranje<\/li>\r\n<\/ul>\r\nTe ugotovitve so utrdile agoniste receptorjev GLP-1 kot temeljne u\u010dinkovine v raziskavah debelosti in presnove.\r\n<h2>Varnostni in regulativni vpogledi<\/h2>\r\nGLP-1 peptide research continues to evolve, with several compounds already approved for clinical use and others in advanced trial phases:\r\n\r\nSemaglutide is FDA-approved for both type 2 diabetes (as Ozempic) and chronic weight management (as Wegovy). It is widely studied in metabolic models and has a well-documented safety profile in both diabetic and non-diabetic populations.\r\n\r\nTirzepatide, a dual GLP-1\/GIP agonist, is also FDA-approved for type 2 diabetes (as Mounjaro) and is under review for obesity-related approvals, following positive SURMOUNT trial data.\r\n\r\nRetatrutide, the triple agonist (GLP-1, GIP, glucagon), remains investigational but has shown groundbreaking results in Phase II trials, with potential to become a new class leader in fat loss and metabolic support research.\r\n\r\n<strong>Pogosto opa\u017eeni u\u010dinki v raziskavah vklju\u010dujejo:<\/strong>\r\n<ul>\r\n \t<li>Slabost<\/li>\r\n \t<li>Zaprtje<\/li>\r\n \t<li>Zaviranje apetita<\/li>\r\n \t<li>Ti so obi\u010dajno odvisni od odmerka in se v dolgotrajnih \u0161tudijah s\u010dasoma zmanj\u0161ajo.<\/li>\r\n<\/ul>\r\n<strong>Navodila za uporabo:<\/strong>\r\n<ul>\r\n \t<li>Uporabite v nadzorovanih laboratorijskih okoljih, osredoto\u010denih na debelost, insulinsko rezistenco ali energijsko presnovo.<\/li>\r\n \t<li>Ohranite sterilno tehniko, hrambo v hladni verigi in dokumentacijo protokolov za ponovljivost.<\/li>\r\n<\/ul>\r\n<strong>Pomemben opomnik:<\/strong>\r\n\r\nVsi obravnavani peptidi so namenjeni izklju\u010dno za uporabo v laboratorijskih raziskavah. Niso odobreni za uporabo pri ljudeh, razen v okviru reguliranih klini\u010dnih presku\u0161anj ali na recept.\r\n<h2>Najbolj\u0161i peptidi GLP-1 za raziskave<\/h2>\r\nPeptidi GLP-1 so revolucionarno spremenili raziskave na podro\u010dju presnove in debelosti. Naslednji peptidi izstopajo po svoji dobro dokumentirani u\u010dinkovitosti v predklini\u010dnih in klini\u010dnih modelih:\r\n<ul>\r\n \t<li><a href=\"https:\/\/cellpeptides.com\/sl\/product\/buy-semaglutide-5mg\/\"><strong>Semaglutid<\/strong><\/a> \u2013 \u0160iroko raziskan agonist receptorja GLP-1, znan po svoji vlogi pri zaviranju apetita, uravnavanju glukoze in zmanj\u0161evanju ma\u0161\u010dobne mase. V dolgoro\u010dnih \u0161tudijah o debelosti je pokazal dosledno izgubo telesne te\u017ee v vi\u0161ini ~15%.<\/li>\r\n \t<li><a href=\"https:\/\/cellpeptides.com\/sl\/product\/buy-tirzepatide-5mg\/\"><strong>Tirzepatid<\/strong><\/a> \u2013 Dvojni agonist GLP-1\/GIP, ki izbolj\u0161a ob\u010dutljivost na inzulin in zmanj\u0161a telesno te\u017eo \u0161e u\u010dinkoviteje kot semaglutid. Klini\u010dne \u0161tudije, kot je SURMOUNT-1, so pri zdravljenih udele\u017eencih zabele\u017eile povpre\u010dno izgubo telesne te\u017ee v vi\u0161ini 22,51 TP3T.<\/li>\r\n \t<li><a href=\"https:\/\/cellpeptides.com\/sl\/product\/buy-retatrutide-5mg\/\"><strong>Retatrutid<\/strong><\/a> \u2013 Trojni agonist nove generacije, ki deluje na receptorje GLP-1, GIP in glukagona. Zgodnje \u0161tudije ka\u017eejo, da omogo\u010da izgubo ma\u0161\u010dobe do 24,21 TP3T, kar ga uvr\u0161\u010da med najmo\u010dnej\u0161e peptide v trenutnih raziskavah na podro\u010dju debelosti.<\/li>\r\n<\/ul>\r\n<h2>Laboratorijska uporaba in rekonstitucija<\/h2>\r\nPeptide GLP-1, kot so semaglutid, tirzepatid in retatrutid, je treba ustrezno rekonstituirati in z njimi ravnati v sterilnih laboratorijskih pogojih, da se ohranita stabilnost in natan\u010dnost pri raziskavah.\r\n\r\n<strong>Rekonstitucija<\/strong>Ve\u010dino peptidov GLP-1 je mogo\u010de rekonstituirati z bakteriostati\u010dno vodo ali sterilno fiziolo\u0161ko raztopino. Topilo po\u010dasi vbrizgajte ob notranjo steno viale, da prepre\u010dite penjenje, in ne\u017eno zavrtite, dokler se popolnoma ne raztopi.\r\n\r\n<strong>Shranjevanje<\/strong>:\r\n<ul>\r\n \t<li>Liofilizirane peptide je mogo\u010de shranjevati na sobni temperaturi in za\u0161\u010ditene pred svetlobo.<\/li>\r\n \t<li>Rekonstituirani peptidi ostanejo stabilni 30\u201360+ dni, \u010de jih hranite v hladilniku pri temperaturi 2\u20138 \u00b0C.<\/li>\r\n<\/ul>\r\n<strong>Doziranje v predklini\u010dnih modelih:<\/strong>\r\n\r\nStandardni odmerki se gibljejo od 0,01 do 0,2 mg\/kg pri mi\u0161ih ali podganah, odvisno od poskusne postavitve in raziskovalnih ciljev.\r\n<h3>Pogoste raziskovalne to\u010dke:<\/h3>\r\n<ul>\r\n \t<li>Sledenje telesni te\u017ei skozi \u010das<\/li>\r\n \t<li>Zaviranje apetita in spremljanje vnosa hrane<\/li>\r\n \t<li>Testi tolerance za glukozo (GTT)<\/li>\r\n \t<li>Analiza mase in sestave ma\u0161\u010dobne blazinice<\/li>\r\n \t<li>Aktivnost inkretinskih hormonov, vklju\u010dno z analizami za inzulin, GLP-1, GIP in glukagon<\/li>\r\n<\/ul>\r\nTi peptidi so namenjeni izklju\u010dno laboratorijskim raziskavam, pri \u010demer je treba pri vsem ravnanju upo\u0161tevati eti\u010dne protokole in najbolj\u0161e sterilne prakse.\r\n<h2>Pogosta vpra\u0161anja<\/h2>\r\n<h3>Kateri peptid GLP-1 povzro\u010di najve\u010djo izgubo ma\u0161\u010dobe?<\/h3>\r\nRetatrutid je v zgodnjih klini\u010dnih presku\u0161anjih pokazal najve\u010dje zmanj\u0161anje telesne te\u017ee (~24%).\r\n<h3>Ali se lahko peptide kombinira za bolj\u0161e rezultate?<\/h3>\r\nObi\u010dajno ne. Retatrutid \u017ee aktivira receptorje GLP-1, GIP in glukagona, zato dodatno kombiniranje (stacking) ni potrebno.\r\n<h3>Kaj naj storim, \u010de se peptid v celoti ne raztopi?<\/h3>\r\nNe\u017eno zavrtite vialo, ne tresite. Rahlo segrevanje (v vodni kopeli pri 37 \u00b0C) lahko pomaga pri raztapljanju.\r\n<h3>Ali obstajajo razlike v afiniteti za receptorje med temi peptidi?<\/h3>\r\nYes. Semaglutide selectively targets GLP-1 receptors, while Tirzepatide and Retatrutide act on multiple receptors for a broader effect.\r\n\r\nTo finish up, GLP-1 peptides represent a leading edge in metabolic research, offering compelling avenues to study fat loss, insulin regulation, and appetite suppression. Peptides such as Semaglutide, Tirzepatide, and Retatrutide have shown significant effects in both preclinical and clinical models, making them valuable tools for obesity and diabetes-related investigations.\r\n\r\nExplore the full GLP-1 peptide catalog at CellPeptides to support your next metabolic research project.\r\n\r\n<\/div>","link":"https:\/\/cellpeptides.com\/sl\/purpose\/glp-1-peptides\/","name":"Raziskovalni peptidi GLP-1","slug":"glp-1-peptides","taxonomy":"product_cat","parent":0,"meta":[],"menu_order":0,"acf":[],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v22.9 - https:\/\/yoast.com\/wordpress\/plugins\/seo\/ -->\n<title>Buy GLP-1 Peptides for Metabolic Studies (In-vitro) - CellPeptides<\/title>\n<meta name=\"description\" content=\"Shop GLP-1 receptor agonists for appetite, glucose &amp; metabolic research - Semaglutide, Tirzepatide, Retatrutide. Fast shipping in USA &amp; EU\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/cellpeptides.com\/sl\/purpose\/glp-1-peptides\/\" \/>\n<meta property=\"og:locale\" content=\"sl_SI\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Buy GLP-1 Peptides for Metabolic Studies (In-vitro) - CellPeptides\" \/>\n<meta property=\"og:description\" content=\"Shop GLP-1 receptor agonists for appetite, glucose &amp; metabolic research - Semaglutide, Tirzepatide, Retatrutide. Fast shipping in USA &amp; EU\" \/>\n<meta property=\"og:url\" content=\"https:\/\/cellpeptides.com\/sl\/purpose\/glp-1-peptides\/\" \/>\n<meta property=\"og:site_name\" content=\"CellPeptides\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"CollectionPage\",\"@id\":\"https:\/\/cellpeptides.com\/purpose\/glp-1-peptides\/\",\"url\":\"https:\/\/cellpeptides.com\/purpose\/glp-1-peptides\/\",\"name\":\"Buy GLP-1 Peptides for Metabolic Studies (In-vitro) - CellPeptides\",\"isPartOf\":{\"@id\":\"https:\/\/cellpeptides.com\/#website\"},\"description\":\"Shop GLP-1 receptor agonists for appetite, glucose & metabolic research - Semaglutide, Tirzepatide, Retatrutide. Fast shipping in USA & EU\",\"breadcrumb\":{\"@id\":\"https:\/\/cellpeptides.com\/purpose\/glp-1-peptides\/#breadcrumb\"},\"inLanguage\":\"sl-SI\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/cellpeptides.com\/purpose\/glp-1-peptides\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\/\/cellpeptides.com\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"GLP-1 Research Peptides\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/cellpeptides.com\/#website\",\"url\":\"https:\/\/cellpeptides.com\/\",\"name\":\"CellPeptides\",\"description\":\"\",\"publisher\":{\"@id\":\"https:\/\/cellpeptides.com\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/cellpeptides.com\/?s={search_term_string}\"},\"query-input\":\"required name=search_term_string\"}],\"inLanguage\":\"sl-SI\"},{\"@type\":\"Organization\",\"@id\":\"https:\/\/cellpeptides.com\/#organization\",\"name\":\"CellPeptides\",\"url\":\"https:\/\/cellpeptides.com\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"sl-SI\",\"@id\":\"https:\/\/cellpeptides.com\/#\/schema\/logo\/image\/\",\"url\":\"https:\/\/cellpeptides.com\/wp-content\/uploads\/2025\/02\/CellPeptides-logo2-lc2.png\",\"contentUrl\":\"https:\/\/cellpeptides.com\/wp-content\/uploads\/2025\/02\/CellPeptides-logo2-lc2.png\",\"width\":697,\"height\":152,\"caption\":\"CellPeptides\"},\"image\":{\"@id\":\"https:\/\/cellpeptides.com\/#\/schema\/logo\/image\/\"}}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Buy GLP-1 Peptides for Metabolic Studies (In-vitro) - CellPeptides","description":"Shop GLP-1 receptor agonists for appetite, glucose & metabolic research - Semaglutide, Tirzepatide, Retatrutide. Fast shipping in USA & EU","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/cellpeptides.com\/sl\/purpose\/glp-1-peptides\/","og_locale":"sl_SI","og_type":"article","og_title":"Buy GLP-1 Peptides for Metabolic Studies (In-vitro) - CellPeptides","og_description":"Shop GLP-1 receptor agonists for appetite, glucose & metabolic research - Semaglutide, Tirzepatide, Retatrutide. Fast shipping in USA & EU","og_url":"https:\/\/cellpeptides.com\/sl\/purpose\/glp-1-peptides\/","og_site_name":"CellPeptides","twitter_card":"summary_large_image","schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"CollectionPage","@id":"https:\/\/cellpeptides.com\/purpose\/glp-1-peptides\/","url":"https:\/\/cellpeptides.com\/purpose\/glp-1-peptides\/","name":"Buy GLP-1 Peptides for Metabolic Studies (In-vitro) - CellPeptides","isPartOf":{"@id":"https:\/\/cellpeptides.com\/#website"},"description":"Shop GLP-1 receptor agonists for appetite, glucose & metabolic research - Semaglutide, Tirzepatide, Retatrutide. Fast shipping in USA & EU","breadcrumb":{"@id":"https:\/\/cellpeptides.com\/purpose\/glp-1-peptides\/#breadcrumb"},"inLanguage":"sl-SI"},{"@type":"BreadcrumbList","@id":"https:\/\/cellpeptides.com\/purpose\/glp-1-peptides\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/cellpeptides.com\/"},{"@type":"ListItem","position":2,"name":"GLP-1 Research Peptides"}]},{"@type":"WebSite","@id":"https:\/\/cellpeptides.com\/#website","url":"https:\/\/cellpeptides.com\/","name":"CellPeptides","description":"","publisher":{"@id":"https:\/\/cellpeptides.com\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/cellpeptides.com\/?s={search_term_string}"},"query-input":"required name=search_term_string"}],"inLanguage":"sl-SI"},{"@type":"Organization","@id":"https:\/\/cellpeptides.com\/#organization","name":"CellPeptides","url":"https:\/\/cellpeptides.com\/","logo":{"@type":"ImageObject","inLanguage":"sl-SI","@id":"https:\/\/cellpeptides.com\/#\/schema\/logo\/image\/","url":"https:\/\/cellpeptides.com\/wp-content\/uploads\/2025\/02\/CellPeptides-logo2-lc2.png","contentUrl":"https:\/\/cellpeptides.com\/wp-content\/uploads\/2025\/02\/CellPeptides-logo2-lc2.png","width":697,"height":152,"caption":"CellPeptides"},"image":{"@id":"https:\/\/cellpeptides.com\/#\/schema\/logo\/image\/"}}]}},"_links":{"self":[{"href":"https:\/\/cellpeptides.com\/sl\/wp-json\/wp\/v2\/product_cat\/48","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/cellpeptides.com\/sl\/wp-json\/wp\/v2\/product_cat"}],"about":[{"href":"https:\/\/cellpeptides.com\/sl\/wp-json\/wp\/v2\/taxonomies\/product_cat"}],"wp:post_type":[{"href":"https:\/\/cellpeptides.com\/sl\/wp-json\/wp\/v2\/product?product_cat=48"}],"curies":[{"name":"dobro igrano","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}